Johnson & Johnson - Index

Johnson & Johnson - report - Index

Committees
of the Board
AUDIT
The Audit Committee, comprised entirely of independent
Directors, helps the Board oversee the Company’s accounting
and reporting practices. It recommends independent public
accountants for appointment by the Board and reviews their
performance; monitors the adequacy of internal accounting
practices, procedures and controls; and reviews all significant
changes in accounting policies.
James G. Cullen, Chairman
Mary Sue Coleman, Ph.D.
Leo F. Mullin
Steven S Reinemund
COMPENSATION & BENEFITS
The Compensation & Benefits Committee, comprised
entirely of independent Directors, establishes the Company’s
executive compensation philosophy and principles and
approves the annual compensation and long-term
incentives for the Company’s directors and executive officers.
The Committee also reviews the philosophy and policies
of the non-Board Management Compensation Committee,
which determines management compensation and
establishes perquisites and other compensation policies
for non-executive employees. Additionally, the Committee
oversees the management of the various retirement, pension,
long-term incentive, savings, health and welfare plans that
cover the Company’s employees.
Arnold G. Langbo, Chairman
Michael M. E. Johns, M.D.
William D. Perez
Charles Prince
FINANCE
The Finance Committee exercises the management authority
of the Board during the intervals between Board meetings. The
Finance Committee is comprised of the Chairman, Presiding
Director and Vice Chairman of the Board.
William C. Weldon, Chairman
James G. Cullen
Christine A. Poon
B O A R D O F D I R E C T O R S A N D C O M M I T T E E S O F T H E B O A R D
NOMINATING & CORPORATE GOVERNANCE
The Nominating & Corporate Governance Committee,
comprised entirely of independent Directors, is responsible
for overseeing corporate governance matters, reviewing
possible candidates for Board membership and recommending
nominees for election. The Committee is also responsible
for overseeing the process for performance evaluations of
the Board and its committees. Additionally, the Committee
reviews the Company’s management succession plans and
executive resources.
Steven S Reinemund, Chairman
James G. Cullen
Arnold G. Langbo
Charles Prince
PUBLIC POLICY
The Public Policy Advisory Committee reviews the Company’s
policies, programs and practices on public health issues
regarding the environment and the health and safety of
employees. The Committee also reviews the Company’s governmental
affairs and policies and other public policy issues
facing the Company. The Committee advises and makes
recommendations to the Board on these issues as appropriate.
The Public Policy Advisory Committee is comprised of
independent Directors and the Company’s General Counsel
and Vice Presidents for Corporate Affairs, Government Affairs
and Policy, and Worldwide Operations.
Leo F. Mullin, Chairman
Russell C. Deyo
Clifford H. Holland
Susan L. Lindquist, Ph.D.
William D. Perez
Brian D. Perkins
David Satcher, M.D., Ph.D.
Ajit Shetty, Ph.D.
SCIENCE & TECHNOLOGY
The Science & Technology Advisory Committee, comprised
of independent Directors and the Company’s Vice President,
Science and Technology, advises the Board on scientific
matters, including major internal projects, interaction
with academic and other outside research organizations,
and the acquisition of technologies and products.
David Satcher, M.D., Ph.D., Chairman
Mary Sue Coleman, Ph.D.
Michael M. E. Johns, M.D.
Susan L. Lindquist, Ph.D.
Garry Neil, M.D.
33